Renalase, stroke, and hypertension in hemodialyzed patients

Renal Failure

Volumn 34, Issue 6, 2012, Pages 727-731

  Malyszko, Jolanta ^a   Koc Zorawska, Ewa ^a   Malyszko, Jacek S ^a   Kozminski, Piotr ^b   Zbroch, Edyta ^a   Mysliwiec, Michal ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Regional Hospital   (Poland)

Author keywords

hemodialysis; hypertension; renalase; residual renal function; stroke

Indexed keywords

CREATININE; HORMONE; RENALASE; TRANSFERRIN; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS PATIENT; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; RISK FACTOR; STROKE;

BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; PILOT PROJECTS; REGRESSION ANALYSIS; RENAL DIALYSIS; STATISTICS, NONPARAMETRIC; STROKE; TRANSFERRIN;

EID: 84862231852     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.681534     Document Type: Article

References (18)

1. USRDS. Available at: http://www.usrds.org/atlas.aspx. Accessed January 4, 2012.
2. Rohr J, Kittner S, Feeser B, et al. Traditional risk factors and ischemic stroke in young adults: The Baltimore-Washington Cooperative Young Stroke Study. Arch Neurol. 1996;53:603-607. (Pubitemid 26242210)
3. Sánchez-Perales C, Vázquez E, García-Cortés MJ, et al. Ischemic stroke in incident dialysis patients. Nephrol Dial Transplant. 2010;25:3343-3348.
4. Power A, Chan K, Singh SK, Taube D, Duncan N. Appraising stroke risk in maintenance hemodialysis patients: A large single-center cohort study. Am J Kidney Dis. 2012;59:249-257.
5. Xu J, Li G, Wang P, et al. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest. 2005;115:1275-1280. (Pubitemid 40629046)
6. Li G, Xu J, Wang P, et al. Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation. 2008;117:1277-1282. (Pubitemid 351365660)
7. Stec A, Semczuk A, Furmaga J, Ksiazek A, Buraczynska M. Polymorphism of the renalase gene in end-stage renal disease patients affected by hypertension. Nephrol Dial Transplant. 2011. in press.
8. Buraczynska M, Zukowski P, Buraczynska K, Mozul S, Ksiazek A. Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and stroke. Neuromol Med. 2011;13:321-327.
9. Farzaneh-Far R, Desir GV, Na B, Schiller NB, Whooley MA. A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: Data from the heart and soul study. PLoS One. 2010;5:e13496.
10. Malyszko J, Zbroch E, Malyszko JS, Koc-Zorawska E, Mysliwiec M. Renalase, a novel regulator of blood pressure, is predicted by kidney function in renal transplant recipients. Transplant Proc. 2011;43:3004-3007.
11. Zbroch E, Malyszko J, Malyszko J, Koc-Zorawska E, Mysliwiec M. Renalase in peritoneal dialysis patients is not related to blood pressure, but to dialysis vintage. Perit Dial Int. 2012;32(3), doi:10.3747/pdi.2011.00118.
12. Wu Y, Xu J, Velazquez H, et al. Renalase deficiency aggravates ischemic myocardial damage. Kidney Int. 2011;79:853-860.
13. Schlaich M, Socratous F, Eikelis N, Chopra R, Lambert G, Hennebry S. Renalase plasma levels are associated with systolic blood pressure in patients with resistant hypertension. J Hypertens. 2010;28:e437.
14. Masuo K, Lambert GW, Esler MD, Rakugi H, Ogihara T, Schlaich MP. The role of sympathetic nervous activity in renal injury and end-stage renal disease. Hypertens Res. 2010;33:521-528.
15. Tripepi G, Mattace-Raso F, Rapisarda F, et al. Traditional and nontraditional risk factors as predictors of cerebrovascular events in patients with end stage renal disease. J Hypertens. 2010;28:2468-2474.
16. Yano Y, Hoshide S, Etoh T, Tamaki N, Yokota N, Kario K. Synergistic effect of chronic kidney disease and high circulatory norepinephrine level on stroke risk in Japanese hypertensive patients. Atherosclerosis. 2011;219:273-279.
17. Zoccali C, Mallamaci F, Parlongo S, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation. 2002;105:1354-1359. (Pubitemid 34260428)
18. Mallamaci F, Tripepi G, Maas R, Malatino L, Böger R, Zoccali C. Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease. J Am Soc Nephrol. 2004;15:435-441. (Pubitemid 38140785)